An independent intelligence board aggregating credible research, preprints, clinical findings, biohacking experiments, and community discussions on therapeutic peptides, longevity science, and evidence-based anti-aging. Stories are scored for relevance, credibility, novelty, momentum, and practicality so the most important findings surface first.
A reader says they were taking the Wegovy pill (the oral form of the weight-loss drug) and lost 35 pounds but recently stopped feeling side effects like nausea and stopped losing weight — in fact they’re regaining weight and feel like the pill stopped working. Their doctor suggested switching to the injected version. This note is a single-person report, not a study. It raises a practical question: can the pill stop working for some people, and is the shot more reliable? Wegovy is the brand name for semaglutide when used for weight loss. Semaglutide is a man-made version of a hormone your gut makes after you eat. That hormone talks to your brain to reduce hunger and slow how quickly your stomach empties, which helps people eat less and lose weight. Semaglutide comes as an injection (the original form many people know) and, more recently, as a pill that’s designed to survive digestion and get into the bloodstream. The person’s experience is an anecdote: one patient reporting initial success, followed by loss of effect. Anecdotes are useful signals but aren’t proof. Clinical trials show the injectable semaglutide reliably reduces appetite and body weight for many people when taken as directed. The oral form is less studied and is trickier to absorb: it has to be taken on an empty stomach with specific timing rules to work. Small differences in how you take it, other medications, changes in gut function, or biological variability could change how much of the drug actually gets into the body. But from this single report we can’t know whether the pill stopped being absorbed, whether the body adapted, or whether other factors (diet, stress, changes in routine, other medicines) caused the weight regain. Why this matters: for someone who relied on the pill and suddenly loses benefit, it affects daily life and health. If the oral form is failing because of absorption issues, switching to the injectable form could restore consistent delivery of the drug and its appetite-suppressing effects. People considering or taking oral semaglutide should know the pill is more sensitive to timing and stomach conditions than the shot. A clinician can help decide whether a route change is appropriate, or whether other causes should be investigated first. Caveats and risks: this report is not a study. The oral semaglutide has rules — typically you must take it on an empty stomach and wait before eating — and breaking those rules can reduce how much drug gets into your system. Side effects like nausea often lessen over time; that can be a good sign but might also coincide with reduced appetite suppression for some people. The injectable form has its own side effects and costs, and not everyone can or should use it. Any switch should be guided by a healthcare provider who knows your full medical history. If you suspect the drug stopped working, don’t change dose or stop abruptly without medical advice. Bottom line: this person’s experience could reflect absorption or individual variation, and switching to the injectable form is a reasonable option to discuss with a doctor, but one anecdote doesn’t prove the pill “stopped working” for everyone.
Source: r/Semaglutide